nuvobio

nuvobio is Startup

NuvoBio is a bio-medical technology company dedicated to expediting the development of peptide therapeutics. Using our novel Darwin AI technology platform to design highly specific binding peptides, we are developing intellectual property and advancing research and development in the areas of new synthetic drugs, immunotherapies and other unique applications.

Powered by our DARWIN AI platform, smart solutions are at the core of all that we do at NuvoBio.

Michael  Cowpland

Michael Cowpland

  • CEO​, Co-Founder
Valentina  Lukinovic

Valentina Lukinovic

  • Research Director
Jim  Stechyson

Jim Stechyson

  • Business Advisor, Co-Founder
Nour  Nissan​

Nour Nissan​

  • Business Development
Kyle  Biggar​

Kyle Biggar​

  • Co-Founder
François  Charih

François Charih

  • Research Scientist​
James  Green

James Green

  • Research Lead, Machine Learning
John  Chapman

John Chapman

  • Accountant, Consultant